To verify the role of CD103+ B cells in the protection, we repeated the experiment with CD103+ depleted B cells from both NLRP6+/+ or NLRP6-/- mice and found no difference in diabetes development (Figure 1M), suggesting CD103+ B cells delayed development of T1D. This evidence concerns the gene NLRP6 and type 1 diabetes mellitus.